Physician profile
Jose Mathew
NPI 1861654659
$27,335.61
in general payments reported to CMS, 2019-2025
36 companies · $2,250 in 2025
The $2,250 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,870 · 2020: $1,906 · 2021: $6,600 · 2022: $6,774 · 2023: $4,189 · 2024: $2,746 · 2025: $2,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,609 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $880 · Travel and Lodging: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,609.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $880.00 |
| Travel and Lodging | $695.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $9,306.56 | 2019-2024 | Ztlido |
| Medtronic, INC. | $5,209.50 | 2021-2025 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,919.83 | 2019-2025 | Relistor |
| Medtronic USA, INC. | $1,676.42 | 2019-2020 | |
| Boston Scientific Corporation | $1,483.54 | 2019-2025 | General - Pain Management, Intracept, Superion Indirect Decompression System |
| Relievant Medsystems, INC. | $1,029.84 | 2023 | Intracept |
| Hydrocision, INC. | $750.00 | 2020 | |
| Spinal Simplicity, LLC | $688.96 | 2024-2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $610.89 | 2019-2025 | Belbuca |
| Nalu Medical, INC. | $595.69 | 2021-2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $556.10 | 2019-2023 | Proclaim |
| Vertos Medical, INC. | $533.08 | 2024 | Mild Device Kit |
| Vertiflex, INC. | $458.07 | 2019 | |
| Curonix LLC | $455.30 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Painteq LLC | $446.68 | 2021-2023 | Painteq |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $359.91 | 2020-2023 | Prolate, Nalocet |
| Stryker Corporation | $277.03 | 2024 | Mild Device Kit, Optablate |
| Horizon Therapeutics Plc | $189.74 | 2020-2022 | |
| Foundation Fusion Solutions, LLC | $133.64 | 2025 | |
| Mdd US Operations, LLC | $103.67 | 2019-2020 | |
| Arteriocyte Medical Systems, INC. | $97.01 | 2023 | Magellan |
| Sentynl Therapeutics, INC. | $73.18 | 2019 | |
| Pfizer INC. | $65.47 | 2019-2021 | |
| Bioventus LLC | $50.57 | 2022 | |
| Biotronik Nro, INC. | $45.90 | 2025 | Prospera |
| Depuy Synthes Sales INC. | $37.03 | 2019 | |
| Daiichi Sankyo INC. | $31.94 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.88 | 2021 | |
| Uswm, LLC | $22.63 | 2022 | |
| Radius Health, INC. | $21.64 | 2021 | |
| Stimwave Technologies Incorporated | $20.69 | 2022 | |
| Biodelivery Sciences International, INC. | $14.05 | 2019 | |
| Almatica Pharma LLC | $12.08 | 2021 | |
| Saluda Medical Americas, INC. | $11.15 | 2023 | Evoke Scs |
| Astrazeneca Pharmaceuticals LP | $11.00 | 2020 | |
| Electronic Waveform Lab, INC. | $9.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.